Cortisone Shot for a Torn ACL: What It Can and Cannot Fix

A cortisone shot for a torn ACL can reduce pain and swelling but cannot heal the ligament. The anterior cruciate ligament does not regenerate after a complete tear, and no injection restores its mechanical stability. Cortisone (a corticosteroid) suppresses inflammation in the joint lining, which eases symptoms temporarily. It is a comfort measure, not a repair.

The distinction matters because the shot's effect is real but limited. Pain relief can arrive within days and last weeks to a few months. Meanwhile the knee remains unstable, and that instability carries its own consequences for cartilage and menisci. Patients and clinicians who treat the injection as a fix rather than a bridge can lose time and risk further damage.

How a cortisone shot works in an injured knee

The ACL is a band of dense collagen connecting the femur to the tibia, and its job is to resist forward translation of the tibia and rotational stress. When it tears, the mechanical restraint is gone. What follows is a cascade of inflammation: damaged cells release mediators that dilate blood vessels, recruit immune cells, and sensitize nerve endings. That is why a torn ACL hurts, swells, and stiffens in the first days.

Corticosteroids are synthetic analogs of cortisol. They bind intracellular receptors and alter gene transcription. One key effect is suppression of phospholipase A2, the enzyme that releases arachidonic acid from cell membranes. Less arachidonic acid means less prostaglandin and leukotriene production, which dampens pain signaling and vascular leak. The drug also reduces pro-inflammatory cytokine expression and immune cell trafficking into the joint.

A single intra-articular injection delivers a high local concentration with low systemic exposure. The joint is a closed compartment, so the drug bathes the synovium directly. Relief follows two paths. First, the chemical suppression of inflammatory mediators reduces nociceptor sensitization. Second, reduced synovial swelling and effusion improves the mechanical feel of the knee. The patient often notices a smoother, less painful arc of motion.

Plain restated: the shot quiets the chemical alarm in the joint but leaves the torn strap unrepaired. The laxity you can feel is unchanged.

What the evidence supports, quantified

The most telling context is the gap between what a corticosteroid can and cannot do in a ligament injury. In clinical practice, intra-articular cortisone typically produces meaningful pain relief for roughly one to three months, and the effect wears off as the drug clears the joint and inflammation returns. Some patients get less, some a bit more. There is no repair of the ligament at any point in that window.

In contrast, a healthy ACL withstands loads on the order of several hundred newtons during ordinary walking and far higher forces during cutting and pivoting. A completely torn ligament loses essentially all of that restraint. No injection re-establishes ligament tension, because the mechanism of action is anti-inflammatory, not structural.

Reconstruction outcomes give useful scale. Contemporary ACL reconstruction reports graft failure or revision in roughly the mid-single digits as a percentage within a few years, depending on graft type, age, and activity. These figures describe surgery, not injection, but they frame the comparison: surgery restores stability with a real failure rate, while cortisone restores comfort with no structural effect at all.

One counterintuitive caveat deserves emphasis. Pain relief can be a hazard. A patient whose knee feels better may return to pivoting activity before the underlying instability is addressed, and an unstable knee can shear the meniscus or scuff the cartilage. Multiple episodes of instability are associated with worse long-term joint health. So the injection can, in a subtle way, increase exposure to the forces that damage the knee.

Edge cases and circumstances that change the picture

Not every torn ACL is the same, and the injection's role shifts with the situation.

Partial tears that retain some fibers behave differently from complete ruptures. A partial tear may preserve some rotational control, and inflammation reduction can make rehabilitation more tolerable. Still, the steroid does not thicken the remaining fibers, and healing of the torn ends depends on the tear pattern and blood supply rather than on the shot.

Acute versus chronic injury is another split. In the first days after injury, the joint is hot, swollen, and often too painful to examine well. A corticosteroid injection can calm that acute inflammatory phase, but many clinicians prefer to wait, because the initial swelling partly reflects protective processes and because infection must be excluded before any needle enters the joint. A hot, swollen knee after trauma is a red flag for joint infection or fracture, and injecting it without evaluation is dangerous.

Patients with certain conditions face added risk. Diabetes can worsen transiently after steroid injection because corticosteroids raise blood glucose. Anticoagulation raises bleeding risk at the needle site. Skin infection near the entry point, or a history of joint infection, makes the injection unsafe. These are reasons a clinician may decline the shot even when pain is severe.

A professional caveat for athletes: the same relief that helps rehabilitation can mask the instability that predicts failure of nonsurgical management. Follow-up with instrumented laxity testing, not just a pain score, tells you whether the knee is actually stable.

Common misconceptions about cortisone and the ACL

Several beliefs circulate widely and are worth correcting plainly.

The first is that cortisone heals the ligament. It does not. Corticosteroids suppress inflammation; they do not stimulate collagen synthesis or reattach torn tissue. No evidence supports ligament regeneration from a steroid injection.

The second is that cortisone weakens the knee. This is overstated for a single injection. Repeated intra-articular corticosteroid injections over months or years are associated with cartilage thinning and bone density loss in some studies, which is why clinicians cap the frequency. A single diagnostic or therapeutic shot is not the same as a chronic injection schedule.

The third is that the shot must be repeated to keep working. Repeated dosing shortens the benefit interval for some patients and raises cumulative risk. The goal should be to use the injection as a bridge to rehabilitation or surgery, not as a maintenance routine.

A related misconception is that pain relief equals healing. A knee can feel substantially better while remaining mechanically unstable. The only way to assess stability is examination, sometimes with imaging or instrumented measurement. Pain scores are a poor proxy for joint integrity.

One nuance often missed: a corticosteroid injection can be part of a broader diagnostic picture. If pain and swelling abate after the shot but mechanical symptoms persist, that pattern points toward instability or a meniscal component rather than pure inflammation.

Comparison with the alternatives

The table makes the trade explicit: cortisone is the fastest way to calm the joint and the slowest to address the problem. Rehabilitation builds function but not a new ligament. Reconstruction rebuilds stability with the cost of surgery. Bracing and NSAIDs are adjuncts. The right combination depends on the patient's age, activity demands, instability on exam, and associated injuries.

Timeline of what to expect after a shot

The timeline holds for a single injection in a typical knee. Timing varies with the severity of inflammation, the presence of meniscal or cartilage injury, and individual response. The fade is the key event: it is the signal to shift from symptom control to a durable plan.

Practical steps and thresholds

The injection is a tool with a narrow job. Using it well means pairing it with decisions that address the instability.

Confirm the diagnosis before injection. A hot, swollen, traumatic knee needs evaluation for infection and fracture before any needle. Stability testing and imaging clarify whether the ACL is completely or partially torn. Set an explicit purpose for the shot. Reasonable goals are bridging to physical therapy, allowing a calmer joint for examination, or short-term comfort in a patient who is not a surgical candidate. Vague relief as the only goal invites repetition without progress. Protect the knee while it feels better. Use a brace or avoid pivoting and cutting until stability is assessed. Relief without restraint is the main way patients get hurt again. Pair the shot with rehabilitation. A structured program of quadriceps and hamstring strengthening, balance work, and gradual loading gives the knee its best nonsurgical chance. Relief makes that work possible; it does not replace it. Track the response, not just the pain score. Note whether swelling returns, whether the knee gives way, and whether mechanical symptoms such as catching or locking appear. These observations guide the next step. Reassess at the fade. When relief wears off, decide among continued rehabilitation, bracing, or surgical consultation. Repeated injections without a plan accumulate risk and delay definitive care.

Red-flag warnings that should stop the process and prompt urgent evaluation:

Fever, chills, or a knee that becomes hot and swollen after injection, which can signal joint infection. Inability to bear weight after trauma, suggesting fracture. A knee that locks or gives way repeatedly despite pain relief. Rapidly worsening swelling in the calf, which can indicate a clot. Signs of infection at the injection site.

Limits of what the injection can and cannot conclude

Two boundaries deserve direct statement. First, the evidence base for intra-articular cortisone specifically in ACL tears is thin compared with the evidence for its use in osteoarthritis. Much of the reasoning here rests on the drug's known anti-inflammatory mechanism and on the well-established fact that a torn ACL does not heal by itself. Extrapolation should be labeled as such.

Second, this article cannot tell any individual what to do. The decision depends on examination findings, imaging, age, activity goals, and other injuries in the same knee. A corticosteroid injection is not a treatment plan; it is one decision among several, and the clinician who examines the knee is the right person to sequence them.

The central fact remains simple and stable. A cortisone shot for a torn ACL can make the knee feel better for a while. It cannot make the knee stable, and it cannot heal the ligament. Planning around that distinction is what separates short-term comfort from long-term function.